|
1
|
Van Meir EG, Hadjipanayis CG, Norden AD,
Shu HK, Wen PY and Olson JJ: Exciting new advances in
neuro-oncology: The avenue to a cure for malignant glioma. CA
Cancer J Clin. 60:166–193. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Franceschi E, Depenni R, Paccapelo A,
Ermani M, Faedi M, Sturiale C, Michiara M, Servadei F, Pavesi G,
Urbini B, et al: Which elderly newly diagnosed glioblastoma
patients can benefit from radiotherapy and temozolomide? A PERNO
prospective study. J Neurooncol. 128:157–162. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang W, Chen J, Dai J, Zhang B, Wang F and
Sun Y: MicroRNA-16-1 inhibits tumor cell proliferation and induces
apoptosis in A549 non-small cell lung carcinoma cells. Oncol Res.
24:345–351. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhou W, Bi X, Gao G and Sun L: miRNA-133b
and miRNA-135a induce apoptosis via the JAK2/STAT3 signaling
pathway in human renal carcinoma cells. Biomed Pharmacother.
84:722–729. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu F, Zhang S, Zhao Z, Mao X, Huang J, Wu
Z, Zheng L and Wang Q: MicroRNA-27b up-regulated by human
papillomavirus 16 E7 promotes proliferation and suppresses
apoptosis by targeting polo-like kinase2 in cervical cancer.
Oncotarget. 7:19666–19679. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhou F, Li Y, Hao Z, Liu X, Chen L, Cao Y,
Liang Z, Yuan F, Liu J, Wang J, et al: MicroRNA-300 inhibited
glioblastoma progression through ROCK1. Oncotarget. 7:36529–36538.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hao Y, Zhang S, Sun S, Zhu J and Xiao Y:
MiR-595 targeting regulation of SOX7 expression promoted cell
proliferation of human glioblastoma. Biomed Pharmacother.
80:121–126. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen H, Lu Q, Fei X, Shen L, Jiang D and
Dai D: miR-22 inhibits the proliferation, motility, and invasion of
human glioblastoma cells by directly targeting SIRT1. Tumour Biol.
37:6761–6768. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gopalan V, Pillai S, Ebrahimi F,
Salajegheh A, Lam TC, Le TK, Langsford N, Ho YH, Smith RA and Lam
AK: Regulation of microRNA-1288 in colorectal cancer: Altered
expression and its clinicopathological significance. Mol Carcinog.
53 Suppl 1:E36–E44. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gopalan V, Islam F, Pillai S, Tang JC,
Tong DK, Law S, Chan KW and Lam AK: Overexpression of microRNA-1288
in oesophageal squamous cell carcinoma. Exp Cell Res. 348:146–154.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zheng F, Zhang J, Luo S, Yi J, Wang P,
Zheng Q and Wen Y: miR-143 is associated with proliferation and
apoptosis involving ERK5 in HeLa cells. Oncol Lett. 12:3021–3027.
2016.PubMed/NCBI
|
|
13
|
Shen L, Liu L, Ge L, Xie L, Liu S, Sang L,
Zhan T and Li H: miR-448 downregulates MPPED2 to promote cancer
proliferation and inhibit apoptosis in oral squamous cell
carcinoma. Exp Ther Med. 12:2747–2752. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tao WY, Wang CY, Sun YH, Su YH, Pang D and
Zhang GQ: MicroRNA-34c suppresses breast cancer migration and
invasion by targeting GIT1. J Cancer. 7:1653–1662. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Song L, Yang J, Duan P, Xu J, Luo X, Luo
F, Zhang Z, Hou T, Liu B and Zhou Q: MicroRNA-24 inhibits
osteosarcoma cell proliferation both in vitro and in vivo by
targeting LPAATβ. Arch Biochem Biophys. 535:128–135. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pan Y, Robertson G, Pedersen L, Lim E,
Hernandez-Herrera A, Rowat AC, Patil SL, Chan CK, Wen Y, Zhang X,
et al: miR-509-3p is clinically significant and strongly attenuates
cellular migration and multi-cellular spheroids in ovarian cancer.
Oncotarget. 7:25930–25948. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu J, Xu J, Li H, Sun C, Yu L, Li Y, Shi
C, Zhou X, Bian X, Ping Y, et al: miR-146b-5p functions as a tumor
suppressor by targeting TRAF6 and predicts the prognosis of human
gliomas. Oncotarget. 6:29129–29142. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xue J, Zhou A, Wu Y, Morris SA, Lin K,
Amin S, Verhaak R, Fuller G, Xie K, Heimberger AB and Huang S:
miR-182-5p induced by STAT3 activation promotes glioma
tumorigenesis. Cancer Res. 76:4293–4304. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Guo E, Wang Z and Wang S: MiR-200c and
miR-141 inhibit ZEB1 synergistically and suppress glioma cell
growth and migration. Eur Rev Med Pharmacol Sci. 20:3385–3391.
2016.PubMed/NCBI
|
|
20
|
Gopalan V, Islam F, Pillai S, Tang JC,
Tong DK, Law S, Chan KW and Lam AK: Overexpression of microRNA-1288
in oesophageal squamous cell carcinoma. Exp Cell Res. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bignell GR, Warren W, Seal S, Takahashi M,
Rapley E, Barfoot R, Green H, Brown C, Biggs PJ, Lakhani SR, et al:
Identification of the familial cylindromatosis tumour-suppressor
gene. Nat Genet. 25:160–165. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Massoumi R: CYLD: A deubiquitination
enzyme with multiple roles in cancer. Future Oncol. 7:285–297.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hayashi M, Jono H, Shinriki S, Nakamura T,
Guo J, Sueta A, Tomiguchi M, Fujiwara S, Yamamoto-Ibusuki M,
Murakami K, et al: Clinical significance of CYLD downregulation in
breast cancer. Breast Cancer Res Treat. 143:447–457. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang L, Ding Y, Yuan Z, Liu J, Sun J, Lei
F, Wu S, Li S and Zhang D: MicroRNA-500 sustains nuclear factor-κB
activation and induces gastric cancer cell proliferation and
resistance to apoptosis. Oncotarget. 6:2483–2495. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ge WL, Xu JF and Hu J: Regulation of oral
squamous cell carcinoma proliferation through crosstalk between
SMAD7 and CYLD. Cell Physiol Biochem. 38:1209–1217. 2016.
View Article : Google Scholar : PubMed/NCBI
|
